KILIMANJARO: THE Moshi-based KCMC Zonal Referral Hospital (KCMC ZRH) has achieved a significant medical milestone after ...

There are different ways to manage fatigue during prostate cancer treatment, including exercise, sleep, complementary ...

Docetaxel added to androgen deprivation therapy (ADT) was the most cost-effective first-line regimen for patients with ...

No significant improvement seen in overall survival with addition of hormone therapy to post-radical prostatectomy radiotherapy.

A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that adding hormone therapy to postoperative radiotherapy may provide little survival benefit for most men ...

The ongoing Daro-PET study set out to evaluate the ability of the oral androgen receptor inhibitor darolutamide (Nubeqa) to ...

The treatment, a type of immunotherapy which harnesses the body’s immune system to fight cancer, was found to shrink tumours ...

Amid Teddi Mellencamp’s ongoing battle with stage four melanoma, she shared she was recently hospitalized for contracting Stevens-Johnson’s syndrome, a rare, life-threatening illness.

A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...

Whole-pelvis RT linked to improved PFS for patients with prostate cancer staged TrN0M0, while ADT linked to improved PFS in patients staged N1/M1.

Dr. Ali Kasraeian from Kasraeian Urology is the first in our area to utilize a new minimally invasive treatment, called Focal Therapy, that precisely targets and destroys prostate cancer tumors.

The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour ...